Traditional Chinese Medicine for Bradyarrhythmia: Evidence and Potential Mechanisms

Shuo Liu, Guihua Tian, Jing Chen, Xiaoyu Zhang, Aiming Wu, Min Li, Yang Sun, Baoshan Liu, Yanwei Xing, Hongcai Shang, Shuo Liu, Guihua Tian, Jing Chen, Xiaoyu Zhang, Aiming Wu, Min Li, Yang Sun, Baoshan Liu, Yanwei Xing, Hongcai Shang

Abstract

Importance: The incidence of Bradyarrhythmias is high among the population. However, at early stages of the disease, it cannot always get enough attention and is lack of safe and effective therapies, until it is serious enough to resort to pacemaker implantation. Traditional Chinese Medicine (TCM) has a long history of treating Bradyarrhythmia, with a lot of formulas being widely used in clinical practice. While the effectiveness and the underlying mechanisms of these formulas have not yet been clearly identified. Objective: To evaluate the effectiveness of some common TCM formulas in treating patients with Bradyarrhythmia and to summarize the current evidence as to their mechanisms. Data Sources: Relevant studies were identified by searching for papers published from January 2000 to August 2017 in Pubmed; EMBASE; the Cochrane Library (Cochrane Central Register of Controlled Trials); the China National Knowledge Internet; and the China biology medicine, Wanfang, and VIP databases. The following medical subject heading (MeSH) terms were included for Pubmed search and adapted for other databases as needed-"Medicine, Chinese Traditional," "Bradycardia." Study Selection: Randomized clinical trials investigating treatment outcomes in Bradyarrhythmia patients with one of the six TCM formulas (Shenxian-shengmai oral liquid, Shensong Yangxin capsule, XinBao pill, Mahuang-Fuzi-Xixin decoction, Zhigancao decoction and Shengmai injection). Data Extraction and Synthesis: Two independent reviewers performed the data extraction and assessed study quality. A meta-analysis was performed to calculate risk ratio (RR) and 95% confidence index (CI) using random-effects and fixed-effects model. Results: A total of 121 clinical trials with 11138 patients were included. Of the six TCM formulas, SXSM (RR:1.33, 95% CI 1.27 to 1.39, P < 0.00001), SSYX (RR:1.52, 95% CI 1.40 to 1.66, P < 0.00001), XB can be more effective than common treatment (RR 1.18, 95% CI 1.11 to 1.26, P < 0.00001), as well as placebo (RR 5.33, 95% CI 2.88-9.87, P < 0.00001), but less effective than TCM dialectical therapy (RR:0.75, 95% CI 0.68 to 0.82, P < 0.00001). Compared to the control group, MFX (RR:1.30, 95%CI 1.23 to 1.37, P < 0.00001), ZGC (RR:1.35, 95%CI 1.23 to 1.48, P < 0.00001), SMI (RR:1.36, 95%CI 1.21 to 1.52, P < 0.00001) can be more effective. The overall quality of the included trials were relatively low, with the limitations of small sample size, inadequate descriptions in randomization, allocation concealment and blinding methods. Conclusions and Relevance: There are evidence that some TCM formulas might help to relieve Bradyarrhythmias. But with the relatively low quality of the clinical trials and mechanism studies, we still need more high-quality researches to verify the conclusions.

Keywords: Bradyarrhythmia; Traditional Chinese Medicine; evidence-based medicine; mechanisms; systematic reviews and meta-analyses.

Figures

Figure 1
Figure 1
Flowchart of the included studies' selection process.
Figure 2
Figure 2
Risk of bias graph (A) SXSM, (B) SSYX, (C) XB, (D) MFX, (E) ZGC, (F) SMI.
Figure 3
Figure 3
SXSM for Bradyarrhythmia efficacy by meta-analysis.
Figure 4
Figure 4
SSYX for Bradyarrhythmia efficacy by meta-analysis.
Figure 5
Figure 5
XB for Bradyarrhythmia efficacy by meta-analysis.
Figure 6
Figure 6
MFX for Bradyarrhythmia efficacy by meta-analysis.
Figure 7
Figure 7
ZGC for Bradyarrhythmia efficacy by meta-analysis.
Figure 8
Figure 8
SMI for Bradyarrhythmia efficacy by meta-analysis.
Figure 9
Figure 9
Four included Chinese patent medicine and their drug instructions (A) SXSM. (B) SSYX. (C) XB. (D) SMI.

References

    1. Bai J., Hou P. (2014). Clinical comparative study of shenxian shengmai oral liquid and tongmai yangxin pills in treatment of slow arrhythmia [in Chinese]. J. Pract. Tradit. Chin. Intern. Med. 28, 37–39. 10.13729/j.issn.1671-7813.2014.05.20
    1. Baman T. S., Kirkpatrick J. N., Romero J., Gakenheimer L., Romero A., Lange D. C., et al. . (2010). Pacemaker reuse: an initiative to alleviate the burden of symptomatic Bradyarrhythmia in impoverished nations around the world. Circulation 122, 1649–1656. 10.1161/CIRCULATIONAHA.110.970483
    1. Bao X., Li Q. (2014). Effective observation of shensong yangxin capsule in the therapy of Bradyarrhythmia [in Chinese]. Xian Dai Yang Sheng 20:240.
    1. Bao Y. (2012). Therapeutic effect of modified mahuang fuzi xixin decoction on patients with Bradyarrhythmia [in Chinese]. Forum Tradit. Chin. Med. 27, 6–7.
    1. Brignole M., Auricchio A., Baron-Esquivias G., Bordachar P., Boriani G., Breithardt O. A., et al. . (2013). 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). developed in collaboration with the European Heart Rhythm Association (EHRA). Eur. Heart J. 34, 2281–2329. 10.1093/eurheartj/eht150
    1. Chen H., Li A., Wu J. (2010). Treatment of Bradyarrhythmia by warming yang and invigorating Qi method: a clinical observation of 41 cases [in Chinese]. J. New Chin. Med. 42, 86–87.
    1. Chen Y., Zhang Y., Deng M., Ma M. (2016). Thirty-Four cases of sinus Bradycardia after cervical spinal cord injury treated with Xinbao Pills [in Chinese]. Henan Tradit. Chin. Med. 36, 435–436. 10.16367/j.issn.1003-5028.2016.03.0189
    1. Cheng H. (2012). Clinical analysis of TCM treatment of Bradyarrhythmia [in Chinese]. Gems Health 11, 105–105.
    1. Cheng Y. (2016). Effective observation of zhigancao decoction in the therapy of Bradyarrhythmia [in Chinese]. Cardiovasc. Dis. J. integr. Trad. Chin. West. Med. 4, 16–17.
    1. Cho Y. L., Hur S. M., Kim J. Y., Kim J. H., Lee D. K., Choe J., et al. . (2015). Specific activation of insulin-like growth Factor-1 receptor by Ginsenoside Rg5 promotes angiogenesis and vasorelaxation. J. Biol. Chem. 290, 467–477. 10.1074/jbc.M114.603142
    1. Dang S., Huang C. X., Wang X., Wang X., Hu J., Huang H. (2016). Shensong Yangxin (SSYX) ameliorates disordered excitation transmission by suppressing cardiac collagen hyperplasia in rabbits with chronic myocardial infarction. J. Huazhong Univ. Sci. Technol. Med. Sci. 36, 162–167. 10.1007/s11596-016-1560-4
    1. Deng Y., Zhang J., Liu G., Sun L. (2014). Effective observation of Mahuang-Fuzi-Xixin decoction in the therapy of Bradyarrhythmia [in Chinese]. J. New Chin. Med. 46, 40–41.
    1. Di G., Zhang X. (2010). On observation of treatment of Bradyarrhythmia by Xinbao Pill [in Chinese]. China Mod. Doct. 48, 86+137. 10.3969/j.issn.1673-9701.2010.25.053
    1. Ding Y. (2016). Effective observation of shensong yangxin capsule in the therapy of Bradyarrhythmia [in Chinese]. Cardiovasc. Dis. J. Integr. Tradit. 4, 161+164. 10.3969/j.issn.2095-6681.2016.22.130
    1. Ding Y., Wei Z., Jin H. (2011). Treating 30 cases of sinus Bradycardia with Shensong Yangxin capsules [in Chinese]. Clin. J. Chillese Med. 3, 53–54. 10.3969/j.issn.1674-7860.2011.24.034
    1. Dong C., Ma X. (2015). Effective observation of Shenxianshengmai oral liquid in the therapy of Bradyarrhythmia [in Chinese]. Cardiovasc. Dis. J. Integr. Tradit. Chin. West. Med. 3, 53+55.
    1. Du G. (2016). Treatment of 42 cases of chronic arrhythmia by adding and removing Mahuang Fuzi Xixin Decoction [in Chinese]. Clin. Res. Pract. 1, 106–107.
    1. Du X. (2014). Clinical experience of Shen Xian Shengmai oral liquid in the treatment of Bradyarrhythmia [in Chinese]. Nei Mongol J. Tradit. Chin. Med. 33:22 10.3969/j.issn.1006-0979.2014.28.024
    1. Fan X., Yang Y. (2005). 45 cases of sinus Bradycardia treated with Mahuang-fuzi-xixin Decoction [in Chinese]. Shaanxi J. Tradit. Chin. Med. 26, 618–619. 10.3969/j.issn.1000-7369.2005.07.006
    1. Fang F. (2005). Observation on the therapeutic effect of traditional Chinese medicine combined with intravenous drip in the treatment of Bradyarrhythmia [in Chinese]. Liaoning J. Tradit. Chin. Med. 32, 31–32. 10.3969/j.issn.1000-1719.2005.01.016
    1. Fang L., Huang H., Sun W. (2014). Clinical observation on the curative effect of modified Mahuang Fuzi Xixin Decoction on treating Bradyarrhythmia [in Chinese]. China Rural Health 15:87.
    1. Gao B., Chen X. (2014). Modified Zhigancao Decoction in treating arrhythmia of Qi and Yin with deficiency syndrome: a clinical study [in Chinese]. J. Pract. Tradit. Chin. Med. 30, 191–192.
    1. Gao F. (2017). Treating 70 cases of Bradyarrhythmia with Shensong Yangxin capsules [in Chinese]. Guide China Med. 15, 213–214.
    1. Gao Y., Tian Y., Wang E. (2005). Simultaneous determination of two active ingredients in Flos daturae by capillary electrophoresis with electrochemiluminescence detection. Anal. Chim. Acta 545, 137–141. 10.1016/j.aca.2005.04.071
    1. Gao Y., Wang X., Xue M. (2016). Curative effect of Xinbao pill in the treatment of Bradyarrhythmia with chronic heart failure [in Chinese]. Inner Mong. Med. J. 48, 471–472. 10.16096/J.cnki.nmgyxzz.2016.48.04.034
    1. Gao Z., Wei Y., Wu L. (2015). Observation on the curative effect of Shen Xian Shengmai oral liquid in the treatment of senile Bradyarrhythmia [in Chinese]. Mod. J. Integr. Tradit. Chin. West. Med. 24, 4079–4080. 10.3969/j.issn.1008-8849.2015.36.034
    1. Ge L. (2010). Shensongyang × in capsule arrhythmia with the clinical effect [in Chinese]. J. Pract. Tradit. Chin. Intern. Med. 24, 52–53. 10.3877/cma.j.issn.2095-6568.2016.01.010
    1. Ge Y. (2010). Clinical observation of 33 cases of chronic atrial fibrillation with long RR interval treated with Shensong Yangxin Capsule [in Chinese]. China Mod. Med. 17, 53–54.
    1. Geng L., Li K., Yang Z. (2010). Treatment of 32 cases of chronic arrhythmia due to Coronary Heart Disease by Mahuang-fuzi-xixin decoction [in Chinese]. Henan Traditi. Chin. Med. 30, 853–854.
    1. Gou Y. (2013). Investigate the clinical efficacy of treatment of fifty sinus Bradycardia by Shensong Yangxin capsules combined with theophylline sustained - release tablets [in Chinese]. Chin. J. Ethnomed. Ethnopharm. 22, 68–69.
    1. Guo X. (2011). Effect observation of Senxianshengmai oral liquid oral liquid and atropine in treatment of Bradycardia arrhythmias [in Chinese]. J. Med. Forum 32, 128–129.
    1. Hai Q. S., Yang Y. Q., Meng Z. R., Jing R. U., Jin Y. J. (2017). Effect of Zhigancao Decoction containing serum on rabbit's isolated vascular smooth muscle. Yunnan J. Tradit. Chin. Med. Mater. Med. 38, 21–25.
    1. Hao P., Jiang F., Cheng J., Ma L., Zhang Y., Zhao Y. (2017). Traditional Chinese medicine for cardiovascular disease: evidence and potential mechanisms. J. Am. Coll. Cardiol. 69, 2952–2966. 10.1016/j.jacc.2017.04.041
    1. He L. (2016). Efficacy and security observation of Shenxianshengmai oral liquid in the therapy of sick sinus syndrome [in Chinese]. Yiayao Qianyan 6, 337–338. 10.3969/j.issn.2095-1752.2016.35.299
    1. Hou P., Chen W., Yu K., Liu N. (2013). Shenxianshengmai oral liquid to cure slow arrhythmia of heart and kidney yang deficiency syndrome randomized controlled study [in Chinese]. J. Pract. Tradit. Chin. Intern. Med, 27, 98–100.
    1. Hu J., Zhao G. (2016). Clinical observation of adenosine cyclophosphate with Xinbao Pills in treating Bradycardia [in Chinese]. World Clin. Med. 10, 93–95.
    1. Hu J., Chen S., Hua X. (2012). Clinical research of Shenxian Shengmai oral liquid on sinus Bradycardiac pa_x0002_tients with sick sinus syndrome [in Chinese] Chin. Tradit. Pat. Med. 34, 7–9. 10.3969/j.issn.1001-1528.2012.01.003
    1. Hu S., Huang L. (2016). Modified Mahuang Fuzi Xixin Decoction in the treatment of Bradyarrhythmia for 51 Cases [in Chinese]. Guangming Journal of Chinese Medicine 31, 2317–2318. 10.3969/j.issn.1003-8914.2016.16.009
    1. Hu Y. (2012). Clinical observation of Zhigancao Decoction in treatment of Bradyarrhythmia [in Chinese]. J. Sichuan Tradit. Chin. Med. 30, 66–67.
    1. Huang X., Zhang H. (2016). Clinical observation on the curative effect of modified Mahuang Fuzi Xixin Decoction on treating Bradyarrhythmia [in Chinese]. China Pract. Med. 11, 202–203. 10.14163/j.cnki.11-5547/r.2016.21.142
    1. Ji L., Zhang Y. (2015). Clinical study on treatment of bradyarrhythmia with modified Mahuang Fuzi Xixin Decoction [in Chinese]. Liaoning J. Tradit. Chin. Med. 42, 986–988. 10.13192/j.issn.1000-1719.2015.05.030
    1. Jia C., Wang S. (2012). Clinical observation of Shen Song Yangxin Capsule on treatment of Bradycardia and ventricular premature contraction [in Chinese]. J. Clin. Ration. Drug Use 5, 52–53. 10.3969/j.issn.1674-3296.2012.07.041
    1. Jia J. (2015). Effective observation of Shenxianshengmai oral liquid in the therapy of sick sinus syndrome [in Chinese]. Cardiovasc. Dis. J. Integr. Tradit. Chin. West. Med. 3, 29+31.
    1. Jiang N., Cen Y., Huang C., Li R. (2012). Clinical observation of Shen Xian Shengmai oral liquid in the treatment of craniocerebral trauma and cerebral cardiac syndrome with sinus Bradycardia [in Chinese]. J. Qiqihar Med. Coll. 33:459 10.3969/j.issn.1002-1256.2012.04.022
    1. Jin Z., Zhang X., Jin H., Qin X., Li N., Pu J. (2010). Observation of therapeutic effect of Shensong Yangxin Capsule on bradycardiac arrhythmia [in Chinese]. Chin. Tradit. Pat. Med. 32, 1287–1291. 10.3969/j.issn.1001-1528.2010.08.004
    1. Keaney J. J., Groarke J. D., Galvin Z., McGorrian C., McCann H. A., Sugrue D., et al. . (2013). The Brady Bunch? New evidence for nominative determinism in patients' health: retrospective, population based cohort study. BMJ 347:f6627. 10.1136/bmj.f6627
    1. Kong J. (2016). Zhigancao Decoction treatment of Bradycardia in 64 cases [in Chinese]. Cardiovasc. Dis. J. Integr. Tradit. Chin. West. Med. 4, 51–52. 10.3969/j.issn.2095-6681.2016.23.042
    1. Larsen B. T., Maleszewski J. J., Edwards W. D., Cooper L. T., Sobonya R. E., Thompson V. E., et al. . (2013). Atrial giant cell myocarditis: a distinctive clinicopathologic entity. Circulation 127, 39–47. 10.1161/CIRCULATIONAHA.112.128900
    1. Li B. (2013). Effective observation of Shenxianshengmai oral liquid in the therapy of Bradycardia [in Chinese]. World Health Dig. 10, 234–234.
    1. Li D. (2016). Effects of trimetazidine combined with heart-pellets on bradyarrhythmia caused by acute inferior myocardial infarction [in Chinese]. Contemporary Med. Symp. 14, 114–115.
    1. Li G. (2011). Treating 20 cases of Bradycardia with Shengxian Shengmai oral [in Chinese]. Clin. J. Chin. Med. 3, 44–45. 10.3969/j.issn.1674-7860.2011.13.021
    1. Li G. (2013). Clinical observation on Shensongyangxin Capsules in the treatment of chronic arrhythmia [in Chinese] Med. Front. 11, 94–95. 10.3969/j.issn.2095-1752.2013.11.082
    1. Li H. (2011). Effect of Shen Xian Shengmai oral liquid combined with theophylline sustained release capsules in the treatment of senile sinus Bradycardia [in Chinese]. People′s Mil. Surg. 54, 124–125.
    1. Li J. (2014). Treatment of 34 cases of Bradyarrhythmia by warming Yang, invigorating qi and activating blood [in Chinese]. J. Pract. Tradit. Chin. Med. 30:609.
    1. Li X., Guo S., Du L. (2008). Effect of Shengmai injection in treating elderly patients with Bradyarrhythmia [in Chinese]. Guide China Med. 6, 113–114. 10.3969/j.issn.1671-8194.2008.11.071
    1. Li Y. (2017). Clinical observation on the curative effect of modified Mahuang Fuzi Xixin Decoction on treating arrhythmiaclinical application of Mahuang Fuzi Xixin Decoction in the treatment of Bradyarrhythmia [in Chinese]. Xin Li Yi Sheng 23, 73–74.
    1. Li Y., Ren W., Liang J., Dou J. (2012). Fuzheng Tongluo, Quyu Huazhuo treatment of Bradyarrhythmia clinical study [in Chinese]. Jilin J. Tradit. Chin. Med. 32, 810–811. 10.3969/j.issn.1003-5699.2012.08.028
    1. Li Y., Yin P., Wang L., Liu H. (2016). Observation curative effect on Shensongyangxin capsules in treatment of chronic arrhythmia [in Chinese]. China Continuing Med. Educ. 8, 182–183. 10.3969/j.issn.1674-9308.2016.16.129
    1. Liang B. (2009). Shensong Yangxin capsule combined with western medicine therapy sinus Bradycardia [in Chinese]. China Prac. Med. 04, 60–61. 10.3969/j.issn.1673-7555.2009.20.037
    1. Liberati A., Altman D. G., Tetzlaff J., Mulrow C., Gøtzsche P. C., Ioannidis J. P., et al. . (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700. 10.1136/bmj.b2700
    1. Lin T. (2017). Clinical observation on Shensongyangxin capsules in the treatment of chronic arrhythmia [in Chinese]. China Health Stand. Manag. 8, 88–90. 10.3969/j.issn.1674-9316.2017.09.051
    1. Liu G., Pan D., Wu Y., Zhuang Y., Yu J. (2016). Efficacy of Shen Xian Shengmai oral liquid in the treatment of bradyarrhythmia in the elderly [in Chinese]. Heilongjiang Med. J. 40, 1145–1146. 10.3969/j.issn.1004-5775.2016.12.035
    1. Liu H. (2017). Effective observation of Shenxianshengmai oral liquid in the therapy of Bradyarrhythmia [in Chinese]. J. ETCM 26, 530–531. 10.3969/j.issn.1004-745X.2017.03.051
    1. Liu J., Li Y. (2010). Effective observation of integrative medicine for the treatment of Bradyarrhythmia [in Chinese]. Chin. Commun. Doct. 12:76 10.3969/j.issn.1007-614x.2010.10.091
    1. Liu J., Chen S., Chen X. (2014). Observation of the effect of permanent pacemaker implantation and Shensong Yangxin capsule in the treatment of Bradyarrhythmia [in Chinese]. Res. Integr. Tradit. Chin. West. Med. 6, 249–250. 10.3969/j.issn.1674-4616.2014.05.008
    1. Liu M., Zhao S., Wang Y., Liu T., Li S., Wang H., et al. (2015). Identification of multiple constituents in Chinese medicinal prescription Shensong Yangxin capsule by ultra-fast liquid chromatography combined with quadrupole time-of-flight mass spectrometry. J. Chromatogr. Sci. 53, 240–252. 10.1093/chromsci/bmu047
    1. Liu S., Yin K., Zhou W., Chen L. (2009). Clinical observation on warming and reinforcing kidney - Yang in treating bradyarrhythmia [in Chinese]. Guangdong Med. J. 30, 1167–1168. 10.3969/j.issn.1001-9448.2009.07.069
    1. Liu Y., Han W., Liu L. (2014a). Clinical observation on XinBao pill in the treatment of chronic arrhythmia [in Chinese] Guiding J. Tradit. Chin. Med. Pharm. 20, 123–124. 10.13862/j.cnki.cn43-1446/r.2014.04.056
    1. Liu Y., Li N., Jia Z., Lu F., Pu J. (2014b). Chinese medicine Shensongyangxin is effective for patients with Bradycardia: results of a randomized, double-blind, placebo-controlled multicenter trial. Evid. Based Complement Altern. Med. 2014:605714. 10.1155/2014/605714
    1. Liu Z. Y., Huang J., Liu N. N., Zheng M., Zhao T., Zhao B. C., et al. . (2017). Molecular mechanisms of increased heart rate in Shenxianshengmai-treated Bradycardia rabbits. Chin. Med. J. 130, 179–186. 10.4103/0366-6999.197999
    1. Long Y. (2016). Effective observation of Zhigancao Decoction in the therapy of bradyarrhythmia [in Chinese]. Asia-Pac. Tradit. Med. 12, 132–133. 10.11954/ytctyy.201617063
    1. Lu X., Liang R., Wang H. (2016). Effective observation of Shenxianshengmai oral liquid in the therapy of sick sinus syndrome [in Chinese]. J. Clin. Psychosom. Dis. 22, 97–97. 10.3969/j.issn.1672-187X.2016.z2.140
    1. Ma J., Zhu Q. (2010). Clinical effects of Wenyang Buxin capsule treatment on 90 patients with chronic arrhythmia and heart-kidney yang asthenia [in Chinese]. Chin. J. TCM WM Cri.t Care 17, 355–357. 10.3969/j.issn.1008-9691.2010.06.012
    1. Ma X., Dong C. (2014). Effective observation of Shenxianshengmai oral liquid and Xinbao pill in the therapy of Bradyarrhythmia [in Chinese]. Chin. J. Tradit. Med. Sci. Technol. 21, 36–37.
    1. Ma Y. (2009). Clinical observation on Shensongyangxin capsules in the treatment of chronic arrhythmia [in Chinese] Qinghai Med. J. 39, 62–63.
    1. Ma Y. (2011). Efficacy of Shenxian Shengmai oral liquid in the treatment of Bradyarrhythmia in Xining area [in Chinese]. Qinghai Med. J. 41, 22–23.
    1. Ning Q. (2004). Mahuangfuzixixin Decoction in the treatment of tachycardia: clinical observation of 60 cases of chronic arrhythmia [in Chinese]. Hunan Guiding J. Tradit. Chin. Med. Pharmacol. 10, 29–30. 10.3969/j.issn.1672-951X.2004.06.014
    1. Pan J., Cui H. (2012). Therapeutic effect of Shensong Yangxin capsule on 600 cases of Bradyarrhythmia [in Chinese]. Chin. Commun. Doctors 14, 185–186. 10.3969/j.issn.1007-614x.2012.26.176
    1. Qiu J. (2012). Treatment of non-organic sinus Bradycardia with zhigancao decoction combined with atropine: a clinical observation of 43 cases [in Chinese]. Beijing J. Tradit. Chin. Med. 31, 921–922.
    1. Rong R., Li R. R., Hou Y. B., Li J., Ding J. X., Zhang C. B., et al. . (2016). Mahuang-Xixin-Fuzi decoction reduces the infection of influenza A virus in Kidney-Yang deficiency syndrome mice. J. Ethnopharmacol. 192, 217–224. 10.1016/j.jep.2016.07.017
    1. Shen N., Li X., Zhou T., Bilal M. U., Du N., Hu Y., et al. . (2014). Shensong Yangxin capsule prevents diabetic myocardial fibrosis by inhibiting TGF-β1/Smad signaling. J. Ethnopharmacol. 157, 161–170. 10.1016/j.jep.2014.09.035
    1. Siqingqimuge (2015). Treatment and nursing of sinus Bradycardia. J. Med. Pharm. Chin. Minor. 21, 80–81. 10.3969/j.issn.1006-6810.2015.06.046
    1. Sun H., Liu S. (2007). The treatment of 99 cases of coronary heart disease with slow ventricular arrhythmia by Shen Song Yangxin capsule [in Chinese]. Shaanxi J. Tradit. Chin. Med. 28, 1195–1196. 10.3969/j.issn.1000-7369.2007.09.066
    1. Sun L., Luo Y. (2015). Effective observation of Shenxianshengmai oral liquid in the adjunctive therapy of slow arrhythmias [in Chinese]. Chin. J. Pharmacoepidemiol. 24, 406–408.
    1. Sun Q., Cao H., Zhou Y., Wang X., Jiang H., Gong L., et al. . (2016). Qualitative and quantitative analysis of the chemical constituents in Mahuang-Fuzi-Xixin decoction based on high performance liquid chromatography combined with time-of-flight mass spectrometry and triple quadrupole mass spectrometers. Biomed. Chromatogr. 30, 1820–1834. 10.1002/bmc.3758
    1. Sun X., Cao J., Zhang M., Kong J., Di X. (2012). Shenxian Shengmai oral liquid combined with nitric acid esters in the treatment of chronic arrhythmia in elderly patients with coronary heart disease [in Chinese]. J. Med. Theory Pract. 25, 2362–2363. 10.3969/j.issn.1001-7585.2012.19.017
    1. Tang H., Li J., Huang Z. (2010). The therapeutic efficacy of Shenxian shengmai oral liquid on patients with sick sinus syndrome [in Chinese]. China Med. 05, 979–980. 10.3760/cma.j.issn.1673-4777.2010.11.005
    1. Tang F., Tang Q., Tian Y., Fan Q., Huang Y., Tan X. (2015). Network pharmacology-based prediction of the active ingredients and potential targets of Mahuang Fuzi Xixin decoction for application to allergic rhinitis. J. Ethnopharmacol. 176, 402–412. 10.1016/j.jep.2015.10.040
    1. Tresch D. D., Fleg L. J. (1986). Unexplained sinus Bradycardia: clinical significance and long-term prognosis in apparently healthy persons older than 40 years. Am. J. Cardiol. 58, 1009–1013.
    1. Wang B. (2016). Clinical observation on Shensongyangxin capsules in the treatment of chronic arrhythmia [in Chinese]. All Health 10:33.
    1. Wang D., Huang J., Yang H. (2014). Clinical observation on Shensongyangxin capsules in the treatment of chronic arrhythmia [in Chinese] Hebei J. TCM 36, 1374–1375. 10.3969/j.issn.1002-2619.2014.09.055
    1. Wang W., Wang T., Yuan J., Liu M., Xu Y., Zhang Q., et al. (2014). The effect of Shensongyangxin capsule in patients with paroxysmal atrial fibrillation and Bradycardiac arrhythmia [in Chinese]. Chin. J. Diffic. Compl. Cas. 13, 939–941. 10.3969/j.issn.1671-6450.2014.09.020
    1. Wang X. (2014). Clinical observation of 30 cases of sinus Bradycardia treated by Shensong Yangxin capsule [in Chinese]. China Prac. Med. 9:186.
    1. Wang X. (2016). Evaluation on treating arrhythmia with the Zhigancao decoction [in Chinese]. Clin. J. Chin. Med. 8, 35–36. 10.3969/j.issn.1674-7860.2016.32.016
    1. Wang X., Liu X. (2012). Effect of Shen Xian Shengmai oral liquid combined with small dose of salbutamol in the treatment of elderly sinus Bradycardia [in Chinese]. Chin. J. Clin. Ration. Drug Use 5, 74–75. 10.3969/j.issn.1674-3296.2012.11.057
    1. Wang Y., Wang J., Yan F. (2012). Clinical research of Shengmai injection on treatment of neonatal Bradycardiac arrhythmia [in Chinese]. Med. Front. 02, 226–227. 10.3969/j.issn.2095-1752.2012.15.241
    1. Wang Z. (2014). Curative effect of modified Jiahe Fuzi Xixin decoction on treating Bradyarrhythmia [in Chinese]. Chin. J. Convalescent Med. 23:1093 10.13517/j.cnki.ccm.2014.12.017
    1. Wei D., Zhou H., Xia X., Hu J. (2015). Investigation of the curative effect of Xin Bao pill in the treatment of elderly patients with sinus Bradycardia [in Chinese]. Chin. Commun. Doct. 31, 92+94. 10.3969/j.issn.1007-614x.2015.2.59
    1. Wei W., Liu H. (2012). 30 cases of Bradyarrhythmia treated with Mahuang-fuzi-xixin Decoction [in Chinese]. Chin. J. Gerontol. 32, 5533–5534. 10.3969/j.issn.1005-9202.2012.24.081
    1. Wu F., Sun H., Wei W., Han Y., Wang P., Dong T., et al. . (2011). Rapid and global detection and characterization of the constituents in ShengMai San by ultra-performance liquid chromatography–high-definition mass spectrometry. J. Sep. Sci. 34, 3194. 10.1002/jssc.201100253
    1. Wu H. (2016). Shensongyangxin capsule treatment efficacy of Bradycardia [in Chinese]. China For. Med. Treat. 30, 128–130. 10.16662/j.cnki.1674-0742.2016.30.128
    1. Wu H., Wei X., Tian D. (2012). Effective observation of Shenxianshengmai oral liquid in the therapy of Bradyarrhythmia [in Chinese]. Guide China Med. 10:237 10.3969/j.issn.1671-8194.2012.03.181
    1. Wu J., Zhu J., Yang X. (2015). Observation of the curative effect of s henxian shengmai oral liquid on the elderly with Bradycardiac arrhythmia [in Chinese]. Gansu Med. J. 34, 184–187.
    1. Wu X. (2017). Effect of Shengmai injection on heart rate and clinical symptoms of patients with Bradyarrhythmia [in Chinese]. Mod. Diagn. Treat. 28, 1195–1196. 10.3969/j.issn.1001-8174.2017.07.012
    1. Wu Y., Zhang C., Chen Z. (2016). Clinical effect of Shensong Yangxin Capsule on frequent ventricular premature beat and sinus Bradycardia [in Chinese]. Chin. Baby 8:113.
    1. Xia H., Wang J., Bao C. (2012). Effect of Shensong Yangxin Capsule in the treatment of frequent atrial premature beat with sinus Bradycardia [in Chinese]. Chin. J. Difficult Complic. Cases 11, 123–124. 10.3969/j.issn.1671-6450.2012.02.019
    1. Xia X., Zhou H., Wei D. (2015). Clinical observation on Xinbao Pill treating 20 cases of senile sinus Bradycardia [in Chinese]. Chin. J. Ethnomed. Ethnopharm. 5, 78–79.
    1. Xu M., Long H. (2014). Clinical observation on the curative effect of modified Mahuang Fuzi Xixin Decoction on treating Bradyarrhythmia [in Chinese]. Med. Informat. 27:431 10.3969/j.issn.1006-1959.2014.35.675
    1. Yang H., Ren Q. (2015). Clinical efficacy of shenxian shengmai oral liquid on senile brady arrhythmia [in Chinese]. J. Liaoning Univ. Tradit. Chin. Med. 17, 160–162. 10.13194/j.issn.1673-842x.2015.11.053
    1. Yang J. H., Han S. J., Ryu J. H., Jang I. S., Kim D. H. (2009). Ginsenoside Rh2 ameliorates scopolamine-induced learning deficit in mice. Biol. Pharm. Bull. 32, 1710–1715. 10.1248/bpb.32.1710
    1. Yang Z., Wang F., Guo Q. (2012). Analysis of the effect and adverse reaction of Shen Xian Shengmai oral liquid in the treatment of Bradyarrhythmia [in Chinese]. Shanxi Med. J. 41, 402–403. 10.3969/j.issn.0253-9926.2012.08.056
    1. Ye J. (2012). Effective observation of Shenxianshengmai oral liquid and theophylline sustained release tablets in the therapy of Sick sinus syndrome [in Chinese]. Chin. J. Integr. Med. Cardio-/Cerebrovasc. Dis. 10, 1176–1177. 10.3969/j.issn.1672-1349.2012.10.015
    1. Yu Q. (2013). Treating 60 cases of Bradyarrhythmia with XinBao pill [in Chinese]. J. Guiyang Coll. Tradit. Chin. Med. 35, 31–33. 10.3969/j.issn.1002-1108.2013.03.0014
    1. Yu S. (2016). Effective observation of Mahuang-Fuzi-Xixin decoction in the therapy of Bradyarrhythmia [in Chinese]. China Healthcare Nutr. 26, 341–342.
    1. Yuan Q. (2016). Clinical observation on the curative effect of modified Mahuang Fuzi Xixin Decoction on treating Bradyarrhythmia [in Chinese]. World Lat. Med. Informat. 16, 208+210. 10.3969/j.issn.1671-3141.2016.100.134
    1. Zálesák M., Blazícek P., Gablovský I., Ledvényiová V., Barteková M., Ziegelhöffer A., et al. . (2015). Impaired PI3K/Akt signaling as a potential cause of failure to precondition rat hearts under conditions of simulated hyperglycemia. Physiol. Res. 64:633.
    1. Zeng X., Li J., Zeng L. (2010). Treating 118 cases of bradyarrhythmia with Shensong Yangxin capsules [in Chinese]. J. Sichuan Tradit. Chin. Med. 28, 81–82.
    1. Zhan S., Fan X., Zhang F., Wang Y., Kang L., Li Z. (2015). A proteomic study reveals Shengmai injection preventing cardiac ischemia-reperfusion injury via energy metabolism modulation. Mol. Biosyst. 11, 540–548. 10.1039/C4MB00161C
    1. Zhang G. (2016). The curative effect of Shensong Yangxin Capsule in the treatment of sinus Bradycardia with ventricular premature beat [in Chinese]. Cardiovasc. Dis. J. Integr. Tradit. Chin. West. Med. 4, 50–51.
    1. Zhang L. (2010). Analysis of the curative effect of Shen Song Yangxin capsule in the treatment of Bradyarrhythmia [in Chinese]. Chin. J. Misdiagn. 10:3870.
    1. Zhang L. (2011). Treatment of 30 Cases of Bradyarrhythmia with Mahuang Fuzi Asarum Decoction and atropine [in Chines]. J. Emerg. Tradit. Chin. Med. 20:468 10.3969/j.issn.1004-745X.2011.03.079
    1. Zhang M., Li N., Qu X. B., Luo S., Drummen G. P. C. (2016). Total velvet-antler polypeptide extract from Cervus nippon Temminck induces cell proliferation and activation of the PI3K–Akt signalling pathway in human peripheral blood lymphocytes. Anim. Prod. Sci. 56:1008 10.1071/AN15103
    1. Zhang P., Li D., Wang X. (2010). Analysis of the curative effect of Shen Song Yangxin Capsule in the treatment of sinus Bradycardia and ventricular premature beat [in Chinese]. Chin. J. Misdiagn. 10, 6576–6577.
    1. Zhang Y. (2013). Clinical analysis of patients with chronic arrhythmia. Guide China Med. 11, 214–215. 10.3969/j.issn.1671-8194.2013.18.154
    1. Zhang Y. (2014). Clinical observation of Shen Xian Shengmai oral liquid in the treatment of hypothyroid sinus Bradycardia [in Chinese]. Mod. Diagn. Treat. 25, 3732–3733.
    1. Zhang Y. (2016a). Clinical observation of Xinbao Pill combined with trimetazidine in treatment of chronic heart failure Induced by Coronary Heart Disease [in Chinese]. Hubei J. Tradit. Chin. Med. 38, 3–5.
    1. Zhang Y. (2016b). Effective observation of Shensong Yangxin Capsule in the therapy of Bradyarrhythmia [in Chinese]. Cardiovasc. Dis. J. integrated Tradit. Chin. West. Med. 4, 30–31.
    1. Zhang Y., Li S. (2016). Curative effect of Xinbao Pills in treating Coronary Heart Disease with atrial fibrillation and long RR interval [in Chinese]. J. Huaihai Med. 34, 338–339. 10.14126/j.cnki.1008-7044.2016.03.043
    1. Zhang Y., Song L., Zhao L., Zhang M., Yang C. (2011). Treating 60 cases of Bradyarrhythmia with Shensong Yangxin capsules [in Chinese]. China Med. Herald 8:192 10.3969/j.issn.1673-7210.2011.13.103
    1. Zhao F., Wang F. (2007). Treatment of sinus Bradycardia with cyclic adenosine monophosphate and Shengmai injection: a clinical analysis of 31 cases [in Chinese]. Chin. J. Coal Ind. Med. 10, 404–405. 10.3969/j.issn.1007-9564.2007.04.033
    1. Zhao J. (2012). Xinbao pill in the treatment of 31 cases of sick sinus syndrome [in Chinese]. Shaanxi J. Tradit. Chin. Med. 33, 46–47. 10.3969/j.issn.1000-7369.2012.01.024
    1. Zhao L. (2010). Effect of Shen Song Yangxin Capsule on sinus Bradycardia [in Chinese]. Chin. J. Ethnomed. Ethnopharm. 19:38 10.3969/j.issn.1007-8517.2010.22.032
    1. Zhao Y., Wei X., Niu J., An C., Liu Y. (2011). Clinical observation of Shensongyangxin capsules in treatment of chronic ar_x0002_rhythmia [in Chinese]. China Med. Herald 8, 71–73. 10.3969/j.issn.1673-7210.2011.03.036
    1. Zheng J. (2011). Clinical observation of method of tonifying Qi to Warm Yang and promote blood flowon sinus Bradycardia [in Chinese]. Shanxi J. Tradit. Chin. Med. 27, 13–14. 10.3969/j.issn.1000-7156.2011.11.008
    1. Zheng K., Zhao M. (2015). Shengmai injection in treatment of slow arrhythmia [in Chinese]. J. Changchun Univ. Chin. Med. 31, 118–120. 10.13463/j.cnki.cczyy.2015.01.040
    1. Zhou J. (2015). Clinical observation of using Shenxian Shengmai Oral liquid to treat 34cases of chronic arrhythmia [in Chinese]. J. Sichuan Tradit. Chin. Med. 33, 115–117.
    1. Zhou J., Yang G. (2016). Clinical efficacy analysis of Fried Glycyrrhizae decoction in treating bradyarrhythmias [in Chinese]. Clin. J. Chin. Med. 8, 38–39. 10.3969/j.issn.1674-7860.2016.09.019
    1. Zhou X., Ma B., Wu J. (2016). ShenXian ShengMai Oral liquid jointed with Aminophy7Iline in treating 32 patients with Bradycardiac Arrhythmia [in Chinese]. West. J. Tradit. Chin. Med. 29, 84–85. 10.3969/j.issn.1004-6852.2016.06.032
    1. Zhu H. (2016). Clinical observation of Mexiletinc combined with Shensongyangxin capsule in the treatment of Bradyarrhythmia [in Chinese]. Gansu Sci. Technol. 32, 128–129+123. 10.3969/j.issn.1000-0952.2016.04.046
    1. Zhu H., Zhang C. (2014). The clinical observation of xinbao pill in the treatment of 50 cases of slow arrhythmia [in Chinese]. Chin. Med. Innovat. 11, 104–106. 10.3969/j.issn.1674-4985.2014.35.038
    1. Zhu W. (2013). A comparative study on curative effect of Xinfukang Capsule and Xinbao Pills in treating Bradyarrhythmia [in Chinese]. Pract. J. Cardiac Cereb. Pneumal Vascul. Dis. 21, 44–45. 10.3969/j.issn.1008-5971.2013.10.019
    1. Zhu Z. (2011). Observation of the efficacy of Shen Song Yangxin Capsule in the therapeutic room with premature beat and sinus Bradycardia [in Chinese]. Chin. J. Integr. Med. Cardio/Cerebrovasc. Dis. 9, 490–491. 10.3969/j.issn.1672-1349.2011.04.055
    1. Zhuo J. (2013). Curative observation of using Shenxian Shengmai oral liquid to treat 54 patients with Bradycardia [in Chinese]. J. Sichuan Tradit. Chin. Med. 31, 88–89.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir